Shaheen, Nour, Shaheen, Ahmed · Medicine · 2022 · DOI
This study examined how COVID-19 affects people's health long after the initial infection, including whether some people develop ME/CFS (myalgic encephalomyelitis) as a result. Researchers planned to survey 20,000 people worldwide about their ongoing symptoms weeks to months after COVID-19 infection, using detailed questionnaires to capture a wide range of both common and unusual long-term effects. The goal was to understand who develops long-term problems and whether COVID-19 can trigger ME/CFS in previously healthy people.
Understanding how frequently ME/CFS develops after COVID-19 infection and what symptoms characterize post-COVID ME/CFS is critical for early recognition and appropriate clinical management. This large international study provides much-needed epidemiological data on the overlap between long COVID and ME/CFS, helping clinicians identify patients who may benefit from ME/CFS-specific care approaches. The findings support recognition of post-infectious ME/CFS as a significant public health concern.
This study does not prove that COVID-19 causes ME/CFS, only that both conditions can occur after infection; establishing causation would require prospective data with documented pre-infection baseline status and mechanistic evidence. The cross-sectional design cannot determine which factors predict who will develop chronic symptoms versus full recovery. Individual symptom prevalence figures are not provided in the abstract, limiting conclusions about disease burden.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.